ConductScience.org, home

Trial · NCT04810091

Results by group44

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percent Change in NTproBNP at 6 Months Visit From BaselinePlacebo + SSA-9.1Inter-Quartile Range -32.4 to 14.3Percent change from baseline
Percent Change in NTproBNP at 6 Months Visit From BaselineXermelo + SSA1.4Inter-Quartile Range -32.4 to 53.8Percent change from baseline
Change in 6MWT at 3 Month VisitPlacebo + SSA0Inter-Quartile Range -35 to 45meters
Change in 6MWT at 3 Month VisitXermelo + SSA8Inter-Quartile Range -25 to 64meters
Change in 6MWT at 6 Month VisitPlacebo + SSA-14Inter-Quartile Range -63 to 39meters
Change in 6MWT at 6 Month VisitXermelo + SSA25.5Inter-Quartile Range -27 to 67meters
Change in CVHD % Score From Baseline to 3 Month VisitPlacebo + SSA0Inter-Quartile Range -7 to 0Scores on a scale
Change in CVHD % Score From Baseline to 3 Month VisitXermelo + SSA0Inter-Quartile Range 0 to 0Scores on a scale
Change in CVHD Score From Baseline to 6 Month VisitPlacebo + SSA0Inter-Quartile Range 0 to 0Scores on a scale
Change in CVHD Score From Baseline to 6 Month VisitXermelo + SSA0Inter-Quartile Range 0 to 0Scores on a scale
Percentage of Participants With Significant Change in Strain-RV From Baseline at 3 MonthsPlacebo + SSA33.395% Confidence Interval 0.8 to 90.6Percentage of Participants
Percentage of Participants With Significant Change in Strain-RV From Baseline at 3 MonthsXermelo + SSA42.995% Confidence Interval 9.9 to 81.6Percentage of Participants
Percentage of Participants With Significant Change in Strain-RV From Baseline at 6 MonthsPlacebo + SSA42.995% Confidence Interval 9.9 to 81.6Percentage of Participants
Percentage of Participants With Significant Change in Strain-RV From Baseline at 6 MonthsXermelo + SSA4095% Confidence Interval 5.3 to 85.3Percentage of Participants
Percentage of Participants With Significant Change in Strain-LV From Baseline at 3 MonthsPlacebo + SSA14.395% Confidence Interval 0.4 to 57.9Percentage of Participants
Percentage of Participants With Significant Change in Strain-LV From Baseline at 3 MonthsXermelo + SSA28.695% Confidence Interval 3.7 to 71.0Percentage of Participants
Percentage of Participants With Significant Change in Strain-LV From Baseline at 6 MonthsPlacebo + SSA13.395% Confidence Interval 1.7 to 40.5Percentage of Participants
Percentage of Participants With Significant Change in Strain-LV From Baseline at 6 MonthsXermelo + SSA12.595% Confidence Interval 1.6 to 38.4Percentage of Participants
Percentage of Participants With Normal TAPSE at 3 MonthsPlacebo + SSA10095% Confidence Interval 47.8 to 100Percentage of Participants
Percentage of Participants With Normal TAPSE at 3 MonthsXermelo + SSA8695% Confidence Interval 42.1 to 99.6Percentage of Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04810091/results